The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(E)-2-cyano-3-(1H-indol-2-yl)-N-phenylacrylamide ID: ALA4092948
Chembl Id: CHEMBL4092948
PubChem CID: 137653238
Max Phase: Preclinical
Molecular Formula: C18H13N3O
Molecular Weight: 287.32
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: N#C/C(=C\c1cc2ccccc2[nH]1)C(=O)Nc1ccccc1
Standard InChI: InChI=1S/C18H13N3O/c19-12-14(18(22)21-15-7-2-1-3-8-15)11-16-10-13-6-4-5-9-17(13)20-16/h1-11,20H,(H,21,22)/b14-11+
Standard InChI Key: QDRWQJFXOXXXEX-SDNWHVSQSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 287.32Molecular Weight (Monoisotopic): 287.1059AlogP: 3.71#Rotatable Bonds: 3Polar Surface Area: 68.68Molecular Species: NEUTRALHBA: 2HBD: 2#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.04CX Basic pKa: ┄CX LogP: 3.40CX LogD: 3.40Aromatic Rings: 3Heavy Atoms: 22QED Weighted: 0.57Np Likeness Score: -1.03
References 1. Vivier D, Soussia IB, Rodrigues N, Lolignier S, Devilliers M, Chatelain FC, Prival L, Chapuy E, Bourdier G, Bennis K, Lesage F, Eschalier A, Busserolles J, Ducki S.. (2017) Development of the First Two-Pore Domain Potassium Channel TWIK-Related K+ Channel 1-Selective Agonist Possessing in Vivo Antinociceptive Activity., 60 (3): [PMID:28051863 ] [10.1021/acs.jmedchem.6b01285 ]